Open AccessModerate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophrenia
Author(s) -
Angèle Consoli,
Valérie Boulicot,
Françoise Cornic,
Philippe Fossati,
Martine Barbeau,
David Cohen
Publication year - 2009
Publication title -
european child and adolescent psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.796
H-Index - 93
eISSN - 1435-165X
pISSN - 1018-8827
DOI - 10.1007/s00787-008-0724-6
Subject(s) - schizophrenia (object oriented programming) , clozapine , electroconvulsive therapy , catatonia , adverse effect , pediatrics , psychiatry , medicine , population , psychology , autonomy , environmental health , political science , law
The use of electro-convulsive therapy (ECT) in adolescents is controversial, and few studies have been conducted to assess its efficacy and safety in this population. We report the case of a 19-year-old boy who received two series of ECT, one at 15 and another at 16, for intractable catatonic schizophrenia. Since the age of 17, he has required treatment combining clozapine and maintenance ECT. The course showed a sustained moderate improvement. The treatment permitted the patient to regain some autonomy with moderate adverse effects. ECT remains an uncommon treatment in adolescents, and the current case supports the view that it should not be banned in young people.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom